Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy DomRuinart

Arrowhead Pharmaceuticals Inc.
Start price
€72.60
28.06.21 / 50%
Target price
€120.00
28.06.22
Performance (%)
-21.07%
End price
€57.30
12.07.21
Summary
This prediction ended on 12.07.21 with a price of €57.30. The price of Arrowhead Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.07%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Arrowhead Pharmaceuticals Inc. -1.187% -1.187% 364.764% 184.003%
iShares Core DAX® 0,44 % 5,64 % 7,81 % 63,64 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 % 88,12 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 % 83,53 %
iShares S&P 500 0,37 % 1,92 % 22,34 % 68,75 %

According to DomRuinart what are the pros and cons of Arrowhead Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -21.07%
Target price 120.000
Change
Ends at 28.06.22

Buy mit Kursziel 120,0

DomRuinart 
0
Report Share
28.06.21
In the thread Trading Arrowhead Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -21.07%
Target price 120.000
Change
Ends at 28.06.22

Buy beendet

DomRuinart 
0
Report Share
12.07.21